Position in BLTE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$538,947
-$19,093 QoQ
Shares Held
3,500
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#52
of 81 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BLTE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026High Net Worth Advisory Group LLC holds $3,297,907 across 9 Biotechnology names. BLTE ranks #1 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BLTE |
Belite Bio, Inc
This page
|
3,500 | $538,947 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
6,000 | $532,680 | |
| 3 | ARGX |
Argenx SE
|
500 | $463,885 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,500 | $451,545 | |
| 5 | CYTK |
Cytokinetics Inc
|
5,000 | $425,950 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,000 | $374,560 | |
| 7 | 3,000 | $370,500 | |||
| 8 | EQ |
Equillium, Inc.
|
33,500 | $107,200 |
All Filings in BLTE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538,947 | 3,500 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $558,040 | 3,500 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $559,860 | 3,500 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $259,000 | 3,500 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||